ID
West Nile Virus Encephalitis
search
West Nile Virus Encephalitis
, West Nile Encephalitis, West Nile Fever, West Nile Virus
See Also
Vector-Borne Infection
Flavivirus
Encephalitis
Epidemiology
Most common vector-borne
Arbovirus
in United States (as of 2016)
Reported cases: ~50,000 between 1999 and 2018
Most severe illness occurs in older patients
Over age 50: Twenty fold risk of severe illness
Timing
Temperate climate: Late summer and early fall
Range of infections: Mid-July to early December
Peaks in late August to early September
Southern climate: Year round transmission
Most favorable weather conditions
Hot,dry summer with brief unseasonably cool weather
Distribution
Africa
First identified in Uganda's West Nile Province (1937)
West Asia
Eastern Europe
Middle East
United States (as of 1999)
Central States
Great Plains States
Pathophysiology
Flavivirus
Mosquito
-borne infection
Transmitted by Culex, Ochlerotatus, Culiseta and Aedes
Mosquito
s
Humans are incidental hosts
Typically cycles between birds,
Mosquito
s and then back to birds
Transmission
Most commonly by
Mosquito Bite
Organ transplant or
Blood Transfusion
(screened in U.S. before transplant or transfusion)
Transplacental transmission
Incubation: 3-14 days
Animals affected
Wild birds are usual hosts
Dead birds may suggest endemic area
Corvids (Crows and Jays) are most often affected
Horses are most affected domesticated animals
Cats
Bats
Chipmunks
Skunks
Squirrels
Rabbits
Types
Asymptomatic Infection (80%)
West Nile Fever (WNF, 20%)
West Nile Neuroinvasive Disease (WNND, 1%)
Meningitis
or
Encephalitis
More severe cases occur in older adults
Risk Factors
Age over 50 years old
Diabetes Mellitus
Alcohol Abuse
Male gender
Organ transplant or
Immunosuppression
Autoimmune Disease
Symptoms
West Nile Fever
Spectrum of disease
See Types above
Symptoms (abrupt onset without prodrome): Flu-like illness
Fever
up to 40 Celsius
Malaise
Muscle Weakness
to
Flaccid Paralysis
Profound
Fatigue
(may persist for weeks)
Chills and myalgias (e.g. back pain)
Drowsiness or lethargy
Variable symptoms
Severe frontal or retro-orbital
Headache
Nausea
or
Vomiting
Eye Pain
Cough
Rare Symptoms
Abdominal Pain
(if hepatitis or
Pancreatitis
)
Classic presentation
Late summer, early fall onset of
Prolonged Fever
and neurologic symptoms
Signs
West Nile Fever
Non-tender
Generalized Lymphadenopathy
Occipital Lymphadenopathy
Axillary Lymphadenopathy
Inguinal Lymphadenopathy
Lymphadenopathy
may persist for months
Facial
Flushing
Conjunctiva
l injection
Coating of
Tongue
Pale maculopapular rash (
Roseola
-like)
Affects trunk and upper arms
Onset on days 2 to 5 (typically as fever subsides)
Signs
Neurologic signs (West Nile Neuroinvasive Disease or WNND)
Severe
Muscle Weakness
to
Acute Flaccid Paralysis
or
Myelitis
(related to anterior horn cell involvement)
No sensory deficits
Ataxia
Decreased or absent
Deep Tendon Reflex
es
Extrapyramidal signs
Myoclonus
Tremor
Cranial Nerve
abnormalities
Myelitis
Optic Neuritis
Polyradiculitis
Seizure
s
Differential Diagnosis
See
Viral Encephalitis
St. Louis
Encephalitis
Dengue
Labs
Gene
ral
Metabolic panel
Hyponatremia
may occur with
Encephalitis
Complete Blood Count
(CBC)
Leukopenia
(
Leukocyte
s <4000/mm3)
Mild
Leukocytosis
may also occur
Lumbar Puncture
Initial
Neutrophilia
, then
Lymphocytosis
Normal
CSF Glucose
Mild increases in
CSF Protein
concentration
Labs
Diagnosis
West Nile Virus serum or CSF IgM by MAC-
ELISA
(preferred)
Best lab test for diagnosis (95% sensitive)
Collect 8-21 days after onset of symptoms (
False Negative
in first 7 days)
Positive CSF IgM confirms
CNS Infection
False Positive
s due to cross reactivity
St. Louis
Encephalitis
virus
Flavivirus
Vaccine
(e.g.
Yellow Fever
,
Dengue
)
Prior West Nile Virus (CSF IgM may persist for a longer period from prior infection)
Other testing (not used routinely)
Blood isolation of virus
Sensitivity on Day 1: 75% of cases positive
Sensitivity decreases over first 5 infection days
Virus
culture of CSF or PCR testing
Imaging
MRI Brain
Abnormal in 25-35% of cases
Nonspecific findings (esp. in
Thalamus
,
Basal Ganglia
)
Complications
Neurologic disease (one in 30-70 cases, some studies report 1 in 150 cases)
Meningitis
Encephalitis
West Nile
Poliomyelitis
-like syndrome
Asymmetric
Flaccid Paralysis
(may include respiratory
Muscle
s)
Guillain-Barre Syndrome
Extrapyramidal symptoms
Long-term neuropsychiatric sequelae
Fatigue
Memory Loss
Difficulty walking
Muscle Weakness
Major Depression
Other complications (rare)
Myocarditis
Chorioretinitis
Cardiac Arrhythmia
s
Pancreatitis
Hepatitis
Rhabdomyolysis
Management
Supportive care in most cases
Hydration
Analgesia
Investigational agents to consider in severe cases
Ribavirin
Interferon Alfa-2B
Prognosis
Most
Mosquito
s in endemic areas are not infected
If infection occurs, 99% of cases are self-limited
Severe cases (meningoencephalitis) occur in less than 1-2% of infections
Mortality in severe cases is 5-15%
Elderly account for majority of fatal cases
Course
Incubation up to 6 days
Duration for 3 to 5 days in 80% of cases
Prolonged recovery may take up to one year to return to full functional and cognitive capacity
Fatigue
may take weeks to months or longer for resolution
Up to 50% of patients have persistent symptoms and functional
Impairment
at >1.5 years
More prolonged course with West Nile Neuroinvasive Disease (WNND)
Prevention
See
Prevention of Vector-borne Infection
Eliminate areas of standing water (and other
Mosquito
control)
No available
Vaccination
Blood donor screening
Resources
CDC West Nile Virus
http://www.cdc.gov/ncidod/dvbid/westnile/
References
Della-Giustina, Fox and Siegel (2021) Crit Dec Emerg Med 35(4): 17-23
Douglas in Goldman (2000) Cecil Medicine, p. 1851
Huhn (2003) Am Fam Physician 68(4):653-72 [PubMed]
Huntington (2016) Am Fam Physician 94(7): 551-7 [PubMed]
Nash (2001) N Engl J Med 3441:1807-1814 [PubMed]
Petersen (2002) Ann Intern Med 137:173-9 [PubMed]
Type your search phrase here